Long-term ALS survival benefit with CNM-Au8 seen in trial analyses
Por um escritor misterioso
Descrição
img_006.jpg
Synapticure on Science: Clinical Trials for Sporadic ALS
Clene Nanomedicine (@CleneNano) / X
Neuromuscular Notes: New and Emerging Therapies in ALS - Practical Neurology
Clene Nanomedicine (@CleneNano) / X
Cells, Free Full-Text
Clene Nanomedicine (@CleneNano) / X
Clene Releases Significant Long-Term Survival Improvement Data from ALS Trial
Form 8-K Clene Inc. For: Mar 14
Full article: CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS)
TDP-43 as a therapeutic target in neurodegenerative diseases: Focusing on motor neuron disease and frontotemporal dementia - ScienceDirect
Innovating Clinical Trials for Amyotrophic Lateral Sclerosis
clnn-ex99_1s3.jpg
de
por adulto (o preço varia de acordo com o tamanho do grupo)